Search

everythinglearnresearchcommunity

for

Search:↓

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

New treatments for lupus show promise, but more research is needed, especially for children.

The combination therapy was effective and well-tolerated, especially in young patients.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Nanotechnology offers promising new treatments for PCOS by reducing inflammation and oxidative stress.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Enhancing antioxidant responses can improve treatments for various diseases.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Targeting the AhR pathway may help treat alopecia areata.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

A woman with hypothyroidism developed an allergy to IV levothyroxine after being resistant to oral forms.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Tigason improved hair growth in a boy with monilethrix without side effects.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.